Featured Article

Imaging of the Glucose Dependent Insulinotropic Polypeptide | tips from the experts

Heather Aug 05, 2026

Imaging of the Glucose

PDF Imaging of the Glucose Dependent Insulinotropic Polypeptide
PDF Imaging of the Glucose Dependent Insulinotropic Polypeptide

Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals. The aim of this study was to evaluate a GIPR-targeting positron emission tomography (PET) radioligand with receptor-specific binding, fast blood clearance, and ...

Out of stock A brief clinical reference for rough equivalency
Out of stock A brief clinical reference for rough equivalency

The glucose-dependent insulinotropic polypeptide receptor (GIPR) is an emerging therapeutic and diagnostic target. Its endogenous ligand is the glucose-dependent in-sulinotropic polypeptide (GIP), which is a 42-mer peptide released from the intestinal K-cells in response to food intake.

(PDF) Imaging of the Glucose

The mechanisms of dual incretin receptor agonists Glucagon like
The mechanisms of dual incretin receptor agonists Glucagon like

Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing ...

The glucose-dependent insulinotropic polypeptide receptor (GIPR) is an emerging therapeutic and diagnostic target. Its endogenous ligand is the glucose-dependent insulinotropic polypeptide (GIP), which is a 42-mer peptide released from the intestinal K-cells in response to food intake.

The dual glucose dependent insulinotropic polypeptide GIP
The dual glucose dependent insulinotropic polypeptide GIP

Characterization of 111In

Many NETs, expressing low somatostatin receptor levels, express glucose-dependent insulinotropic polypeptide (GIP) receptors (GIPR). Here, we evaluated the performance of [Lys 37 (DTPA)]N-acetyl-GIP 1-42, a newly synthesized GIP analogue to investigate whether NET imaging via GIPR targeting is feasible.

Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals.

Figure 1 from Glucose Dependent Insulinotropic Polypeptide Stimulation
Figure 1 from Glucose Dependent Insulinotropic Polypeptide Stimulation

The Glucose

glucose-dependent insulinotropic polypeptide receptor (GIPr) neuroendocrine tumors (NETs) 111 In 68 Ga imaging The regulatory peptides and their receptors have gained an important role in the targeted imaging and radionuclide therapy of cancer over the last few decades. Overexpression of the receptors on the surface of cancer cells, in combination with their considerably low expression in ...

The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies Eleni Gourni1-3, Beatrice Waser4, Pascal Clerc5, Daniel Fourmy5, Jean Claude Reubi4, and Helmut R. Maecke2

Out of stock A brief clinical reference for rough equivalency
Out of stock A brief clinical reference for rough equivalency

Key Details About Imaging Of The Glucose Dependent Insulinotropic Polypeptide

Glucose-dependent insulinotropic polypeptide (GIP) was the first incretin identified and plays an essential role in the maintenance of glucose tolerance in healthy humans. Until recently GIP had not been developed as a therapeutic and thus has been ...

Figure 1 from Effect on Hemoglobin A1c HbA1c and Body Weight After
Figure 1 from Effect on Hemoglobin A1c HbA1c and Body Weight After
PDF Mechanisms underlying glucose dependent insulinotropic
PDF Mechanisms underlying glucose dependent insulinotropic
Glucose dependent insulinotropic polypeptide receptor GIPR gene
Glucose dependent insulinotropic polypeptide receptor GIPR gene
PDF Glucose dependent insulinotropic polypeptide and dipeptidyl
PDF Glucose dependent insulinotropic polypeptide and dipeptidyl
dependent insulinotropic polypeptide hba1c
dependent insulinotropic polypeptide hba1c
PDF Differential effects of glucose dependent insulinotropic
PDF Differential effects of glucose dependent insulinotropic
Figure 2 from Effect on Hemoglobin A1c HbA1c and Body Weight After
Figure 2 from Effect on Hemoglobin A1c HbA1c and Body Weight After
Nephroprotective Properties of the Glucose Dependent Insulinotropic
Nephroprotective Properties of the Glucose Dependent Insulinotropic

Glucose-dependent insulinotropic polypeptide (GIP) was the first incretin identified and plays an essential role in the maintenance of glucose toleran…